Platelet-Activating Factor Acetylhydrolases (PAF-AH)

Fuyu Tamanoi is a biochemist who has served on the UCLA School of Medicine and UCLA College faculty since he joined the Department of Microbiology, Immunology & Molecular Genetics in 1993. He became a full professor in 1997. Dr. Diana Stafforini works at the Huntsman Cancer Institute at the University of Utah School of Medicine. Professor Inoue works at the Teikyo University, School of Pharmacy, Japan.

Overview of PAF Degrading Enzymes
Ken Karasawa and Keizo Inoue
Intracellular PAF Acetylhydrolase Type I
Mitsuharu Hattori and Hiroyuki Arai
Platelet-Activating Factor Acetyl Hydrolase and Brain Development
Gary D. Clark
Intracellular Platelet Activating Factor (PAF) Acetylhydrolase, Type II: A  Unique Cellular Phospholipase A2 that Hydrolyzes Oxidatively-Modified Phospholipids
Nozomu Kono and Hiroyuki Ara
Trafficking and Oligomeric Regulation of Platelet-Activating Factor         Acetylhydrolase Type II
Meghan M. Klems and Brian J. Bahnson
Plasma PAF-AH (PLA2G7): Biochemical Properties, Association with LDLs and HDLs, and Regulation of Expression
Diana M. Stafforini
Crystal Structure and Atomic Level Analysis of Plasma PAF-AH 
Tara D. Gonzalez and Brian J. Bahnson
Naturally Occurring Missense Mutation in Plasma PAF-AH Among the  Japanese Population
Ken Karasawa
Plasma PAFAH/PLA2G7 Genetic Variability, Cardiovascular Disease and Clinical Trials
Sonia Karabina and Ewa Ninio
Diverse Functions of Plasma PAF-AH in Tumorigenesis
Diana M. Stafforini